Grey Innovation Attends the Australia-Germany Advisory Group in Berlin

During July, Grey Innovation was invited to attend the Chamber Delegation for the first meeting of the Australia-Germany Advisory Group in Berlin (Germany). This group was formed to strengthen collaborative innovation between Australia and Germany, and is co-chaired by the Australian Minister for Finance, Mathias Cormann, and the German Minister of State, Professor Dr Maria Böhmer.

Grey Innovation was delighted to be presented at this forum as a successful business case study of collaboration between the two countries, with Grey’s second office located in Garching/Munich (Germany).

Pictured (top) is Grey Innovation CEO, Gilbert Michaca, and Grey Innovation Germany Business Development Manager, Peter Gersing, with Mathias Cormann at the Reichstag (Parliament) in Berlin, (below) Gilbert Michaca and Professor Dr Maria Böhmer.

Posted on August 26, 2015 .

BIONIC EYE POISED FOR 2016 HUMAN TRIALS

07 MAY 2015
The Bionic Eye project is set to perform their first human trial as soon as next year. The Monash Vision Group, a collaboration between Monash University, Alfred Health, MiniFAB and Grey Innovation, is building a bionic eye that bypasses the eye. This device has the potential to help many of the 500,000+ Australians are considered clinically blind.
For the full article: www.theage.com.au

Posted on May 7, 2015 and filed under Medtech.

MASSACHUSETTS LIFE SCIENCES CENTRE FUNDS INTERNATIONAL PARTNERSHIP WITH GREY INNOVATION

18 MARCH 2015
The MLSC’s International Collaborative Industry Program funds partnerships between Massachusetts companies and international companies. “As the global leader in life sciences, Massachusetts has a unique ability to work with other regions of the world to improve health care through innovation,” said Governor Charlie Baker. The ICIP program is supporting Grey Innovation’s partnership with Triton Systems Inc. For this collaboration, the team will combine Grey Innovation’s non-invasive wrist-worn ypoglycaemia detection device and Triton’s mobile disease management solution to develop an m-Health system for monitoring and managing otherwise potentially fatal hypoglycemic events in Type-1 diabetes. The system will ensure personal health privacy and improve patient compliance and outcomes.
www.masslifesciences.com

 

Posted on March 18, 2015 and filed under Medtech.

MONASH'S BIONIC EYE CLOSER TO HUMAN TRIALS

17 DECEMBER 2014
Monash’s Bionic Eye project has received a $3 million boost, which will allow the project to transition from the engineering phase to human clinical trials next year.
As announced in the Age article, ‘Monash’s bionic eye closer to human trials’ (2/12/2014), Monash Vision Group announced that Dr Marc Bensen and Monash University Chancellor Alan Finkel have each donated $1 million to the project through their respective foundations.  Monash University has matched this commitment, adding a further $1 million to the project.
"This comes at a very good time as it will get us to human trials just as the Australian Research Council funding comes to an end," Monash Vision Group director Arthur Lowery said.
"It means we can keep the team together and the expertise and know-how which is so critical to high-tech projects."
The Monash Vision Group is a collaboration between Monash University, Alfred Health, MiniFAB and Grey Innovation.
The team is developing a device that restores sight by wirelessly transmitting signals to an implant placed directly on the region of the brain that processes vision signals. This can provide treatment for the majority of currently un-treatable forms of blindness.
For the full article see:
www.theage.com.au

 

Posted on December 17, 2014 and filed under Medtech.

DSDBI ANNOUNCES GREY’S INVOLVEMENT IN DBIP

15 SEPTEMBER 2014
In an exceptional move, two of Grey’s Technology Solutions have been selected for the Victorian Government’s Driving Business Innovation Programs (DBIP). Over the coming months Grey will deliver feasibility studies into both a Non-Invasive Bedside Lung Imaging device, and a Novel Non-invasive Heart Failure device.

DBIP supports Victorian SMEs to develop new products and services for government agencies. Technology Challenge submissions selected from Victorian hospitals are open to tender response from Victorian SMEs. SMEs are selected by the hospitals based on the quality of their solution and work with the hospitals to produce a feasibility study into the solution.

Through this program Grey is currently working with The Royal Children’s Hospital, to investigate a real-time lung-imaging device that will allow for the safe intubation and subsequent ventilation of unwell children, without the use of an X-Ray. Additionally, Grey is working with Alfred Health to investigate a non-invasive method to monitor fluid status in heart failure patients, which will help identify fluid buildup and allow earlier intervention before it results in an adverse health event.

 

Posted on September 15, 2014 and filed under Medtech.

GREY LAUNCHES TRACK ALERT SYSTEM (TAS) AT INNOTRANS 2014

26 AUGUST 2014
Grey is exhibiting at the Berlin Innotrans Trade Fair late September this year, the largest exhibition globally for railway technology.
Innotrans will see Grey Innovation launching their new Track Alert System (TAS) for rail safety.
TAS is a world first mobile automatic track warning system that provides an additional safety layer for track workers above the safety systems in place at the worksite.
There is no comparable product to TAS today; the Track Alert System far exceeds the current manual lookout system, which saw increased fatalities around rail infrastructure as a result of distraction, fatigue and poor communication.
TAS is a reliable and robust system, providing a novel use of sensors and correlation algorithm to allow train detection with a 100% detection success rate.
TAS is an easy to use, fast to install wireless system. It is also lightweight and portable, making it user friendly and ideal for short term rail maintenance.
TAS has attracted national and global interest from rail operators, and is expected to have applications in both private and public rail safety including mining and rail sectors.
www.innotrans.de

 

Posted on August 26, 2014 and filed under Safety.

UNIVERSITY OF TASMANIA LICENCES GROUNDBREAKING EXPLOSIVES DETECTION TECHNOLOGY IN COLLABORATION WITH GREY

25 JULY 2014
The University of Tasmania has stepped up the fight against terrorism by licensing two technologies, Scantex and CEScan, to Melbourne based technology commercialisation firm Grey Innovation.
Scantex and CEScan have been developed in collaboration with Australian forensic and policing authorities to detect homemade explosives, such as those used in London, Madrid, Bali, and Boston. 
CEScan is the first comprehensive instrumentation in the world to detect the full range of explosives, including military, commercial and homemade inorganic and peroxide explosives, overcoming the limitation of existing screening techniques that struggle to detect modern explosives. CEScan with its breadth of capability is expected to find application in centralised analytical environments such as forensic and customs laboratories.
Using the same base technology, Scantex has been designed as a field deployable version of CEScan system that provides fast detection of homemade explosives, making it ideal for use in airports and similar high-throughput environments. 

The Scantex technology has shown recent success with both Homeland Security and IHS Jane’s Airport Review.

www.ihsairport360.com

Posted on July 25, 2014 and filed under Safety.

CYNATA ANNOUNCES PARTNERSHIP WITH GREY TO DELIVER CYMERUSTM STEM CELLS INTO THE LUNG

cyntha.png

16 JUNE 2014
Cynata on 11 June 2014 announced plans to partner with Grey Innovation to develop potential treatments for lung disorders through enabling the direct delivery of Cymerus stem cells into the lung. The delivery of stem cells into the lung requires a specialised nebuliser system which delivers viable cells. This specialised nebuliser, called RespireTM, has been developed at Monash University and is being commercialised by a team from RMIT, Eastern Health, and Grey Innovation.

 

Posted on June 16, 2014 and filed under Medtech.

VERDE GOLD SPONSOR OF DANII MEADS-BARLOW JELLYBEAN BALL

14 JUNE 2014
Verde is sponsoring the 3rd annual Danii Meads-Barlow Jelly Bean Ball, to be held on 14th June 2014 at the Sofitel Wentworth Sydney. This fundraising event is in support of people living with Type 1 diabetes with a focus on preventing ‘Dead in Bed’ Syndrome by ensuring that the latest technologies are available to alert carers to life threatening hypoglycaemia events.
danii.org.au

Posted on June 14, 2014 and filed under Medtech.